TELA Bio, Inc.
For the period ended Sep 30, 2026. Filed Nov 10, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2026 · Filed Nov 10, 2026
TELA$0.80-7.5%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 1A. Risk Factors
You should carefully consider the risk factors described in our Annual Report and our Quarterly Reports, under the caption “Item 1A. Risk Factors.” There have been no material changes in our risk factors disclosed in our Annual Report and Quarterly Reports.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.